Loading...

Odonate Therapeutics, Inc.

ODTCPNK
Healthcare
Biotechnology
$22005.00
$5005.00(29.44%)

Odonate Therapeutics, Inc. (ODTC) Stock Overview

Explore Odonate Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap24.1B
P/E Ratio8606.13
EPS (TTM)$20580.00
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$59124.42

ODTC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Odonate Therapeutics, Inc. (ODTC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $59124.42.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 8606.13 and a market capitalization of 24.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;